Pharmacology of cyclooxygenase-2 inhibition in the kidney
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 61 (4) , 1210-1219
- https://doi.org/10.1046/j.1523-1755.2002.00263.x
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Enhanced Cyclooxygenase-2 Expression in Sporadic and Familial Adenomatous Polyposis of the Human ColonScandinavian Journal of Gastroenterology, 2001
- Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxenVeterinary Immunology and Immunopathology, 2001
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- Cyclooxygenases and the Central Nervous SystemProstaglandins, 1997
- Adverse Interactions Between Warfarin and Nonsteroidal Antiinflammatory Drugs: Mechanisms, Clinical Significance, and AvoidanceAnnals of Pharmacotherapy, 1995
- Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenaseBiochemical Journal, 1995
- Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.Proceedings of the National Academy of Sciences, 1994
- NSAIDs and gut toxicityThe Lancet, 1994
- Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Proceedings of the National Academy of Sciences, 1994
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971